Showing results (41-50 of 106) with videos related to

Sort By:
Pageof 11
Blood|October 30, 2009
Alpha-defensins secreted by dysplastic granulocytes inhibit the differentiation of monocytes in chronic myelomonocytic leukemiaNathalie Droin, Arnaud Jacquel, Jean-Baptiste Hendra, et al.
Human Molecular Genetics|October 4, 2017
A constitutive BCL2 down-regulation aggravates the phenotype of PKD1-mutant-induced polycystic kidney diseaseLaurence Duplomb, Nathalie Droin, Olivier Bouchot, et al.
Haematologica|December 15, 2018
Downregulation of TREM-like transcript-1 and collagen receptor α2 subunit, two novel RUNX1-targets, contributes to platelet dysfunction in familial platelet disorder with predisposition to acute myelogenous leukemiaAna C Glembotsky, Dominika Sliwa, Dominique Bluteau, et al.
The Journal of Clinical Investigation|March 31, 2015
Specific molecular signatures predict decitabine response in chronic myelomonocytic leukemiaKristen Meldi, Tingting Qin, Francesca Buchi, et al.
Cell Death and Differentiation|March 3, 2023
A noncanonical response to replication stress protects genome stability through ROS production, in an adaptive mannerSandrine Ragu, Nathalie Droin, Gabriel Matos-Rodrigues, et al.
International Journal of Biological Sciences|February 16, 2026
NOX4-derived oxidative DNA damage impairs thyroid differentiation through an epigenetic mechanism in BRAF-mutated radioactive iodine refractory papillary thyroid cancer cellsMickaëlle Radom, Camille Buffet, Juliana Cazarin, et al.
Blood|January 16, 2013
Clonal architecture of chronic myelomonocytic leukemiasRaphaël Itzykson, Olivier Kosmider, Aline Renneville, et al.
British Journal of Haematology|April 24, 2024
Prognostic impact of genetic abnormalities in 536 first-line chronic lymphocytic leukaemia patients without 17p deletion treated with chemoimmunotherapy in two prospective trials: Focus on IGHV-mutated subgroups (a FILO study)Florence Nguyen-Khac, Marine Baron, Romain Guièze, et al.
Nature Communications|January 10, 2026
Single-cell multiplex approaches deeply map ON-target CRISPR-genotoxicity and reveal its mitigation by palbociclib and long-term engraftmentJulian Boutin, Sabrina Fayet, Victor Marin, et al.
Oncology Letters|October 29, 2021
Involvement of PBRM1 in VHL disease-associated clear cell renal cell carcinoma and its putative relationship with the HIF pathwaySophie Gad, Gwenaël Le Teuff, Baptiste Nguyen, et al.
Pageof 11